Leadership Team
Braindoot’s leadership team brings more than 100 years of combined experience across translational science, medicinal chemistry, neuro-oncology, clinical development, biotechnology operations, and company building.
Co-Founder & Chief Executive Officer
Geeta Singh
Geeta Singh leads Braindoot’s corporate strategy, fundraising, partnerships, and enterprise development. With more than 20 years of biotechnology leadership at Genentech and SmartLabs, she has extensive experience in bioprocess development, GMP operations, quality systems, laboratory operations, and organizational scale-up. She is focused on building Braindoot into a precision brain-targeting platform company.
Expertise: Biotechnology Operations • Corporate Strategy • Fundraising
Co-Founder & Chief Operating Officer
Karthika Nair, MSc
Karthika Nair oversees operational strategy, scientific coordination, and program execution across Braindoot’s integrated platforms and pipeline, ensuring disciplined execution from research through preclinical development.
Expertise: Program Management • Scientific Operations • Execution
Co-Founder, Chief Scientific Officer & Board DirectoR
Pradip K. Majumder, PhD
Dr. Majumder is an internationally recognized cancer biologist, entrepreneur, and translational scientist with more than 25 years of experience in oncology research, precision medicine, and drug discovery. He leads Braindoot’s scientific strategy, platform innovation, and therapeutic pipeline.
Expertise: Cancer Biology • Drug Discovery • Platform Innovation
Co-Founder & Clinical Advisor
Santosh Kesari, MD, PhD
Dr. Kesari is an internationally recognized neuro-oncologist with more than 25 years of experience leading brain tumor research and clinical trials. He provides leadership in clinical strategy, translational medicine, biomarkers, and regulatory planning.
Expertise: Neuro-Oncology • Clinical Development • Precision Medicine
Head of Chemistry & Platform Development
Ahmed Aman, PhD
Dr. Aman is a medicinal chemist and drug discovery scientist with more than 25 years of experience in medicinal chemistry, ADME, pharmacokinetics, and linker technologies. He leads chemistry strategy for Braindoot’s precision brain-targeting platform.
Expertise: Medicinal Chemistry • Brain Targeting • Lead Optimization
Clinical Advisor
Fabio Iwamoto, MD
Dr. Iwamoto is a neuro-oncologist specializing in glioblastoma, metastatic brain tumors, and translational neuro-oncology. He advises Braindoot on clinical strategy, biomarker integration, and future clinical development.
Expertise: Glioblastoma • Clinical Trials • Translational Medicine
